| FIBROBIOLOGICS INC. |
| USA |
| Gesundheit |
| US31573L1052 / A3EP67 |
| SG0 (Frankfurt) / FBLG (NASDAQ) |
| FRA:SG0, ETR:SG0, SG0:GR, NASDAQ:FBLG |
| - |
| https://fibrobiologics.co.. |
|
Fibrobiologics Inc. is a cutting-edge biotechnology company involved in the field of regenerative medicine. This company's primary focus is on the development of fibroblast-based technologies and therapies aimed at repairing and regenerating damaged ..
>Volltext.. |
| 4.05 Mio. EUR |
| 1.93 Mio. EUR |
| - |
| -13.7 Mio. EUR |
| -16.15 Mio. EUR |
| -0.38 EUR |
| 2.09 Mio. EUR |
| 4.24 Mio. EUR |
| -14.2 Mio. EUR |
| 2.78 |
| - |
| -47.25% |
| - |
| - |
| - |
| - |
| FIBROBIOLOGICS |
| 05.04.26 |
|
||||
|
||||
|